While initially designed to treat anxiety and depression [42], it was shown to be a more potent LDCD inducer, destabilizing the lysosomal membrane to promote the release of cathepsins resulting in cathepsin-mediated death in tumor cells [43,44]. This evidence concerns the gene CTSS and major depressive disorder.